· Las Heras & Pérez del Valle
IESE authors on why companies flatten and how to do it well.
The verified library of the self-management field: the articles, podcasts, papers and cases worth knowing, from Corporate Rebels to HBR to SciELO, each with a one-line read and a link to the source. Distinct from our own writing in the Library. See the field mapped →
· Las Heras & Pérez del Valle
IESE authors on why companies flatten and how to do it well.
· Bayer
Bayer's own description: management layers halved, management roles cut by two-thirds, 'span of coaching', 3,500 DSO champions, €2B savings target.
· Fortune
The announcement: 99% of the handbook scrapped, ~100,000 employees to self-manage in 90-day projects.
· Fortune
Follow-up on the scale of manager reductions.
· Ryan Hogg
Anderson: 'the belly of the beast of bureaucracy is the budget process'; voluntary attrition down.
· Lee Clifford
Budgets reallocated every 90 days; drug teams compressing time to trials; Wall Street unconvinced.
· CNBC
Frames Bayer inside the 'Great Flattening' trend; 12,000 job cuts, headcount ~90,000.
· Chris Westfall
Sceptical assessment one year in.
· Peter Fisk
Long-form account incl. the Handelsblatt Research Institute employee survey on hierarchy and bureaucracy.
· Liberty Mind
Notes Anderson's earlier Roche experiments and his appearances at Teal Around the World.
· Dr Dre (Medium author)
Context piece on Monsanto litigation, patent cliffs and the DSO bet.
· Ingmar Höhmann
Bayer's chief talent officer on cutting from twelve to five hierarchy levels and what others can learn.
· HRM
Argues self-organisation shifts rather than removes admin work ('boomerang effect'); calls Bayer the most ambitious experiment.
· Gutscher & Rismansanj
Academic article on participation in social enterprises incl. Premium-Cola.
· Lisa Gill
Report from a Bayer session: 4 franchises to 68 squads, 50,000 hours reclaimed; contrasts Bayer's lay-offs with NER's no-lay-off rule.
· Substack author
Analysis of the first 170 DSO teams and the enabling role of finance, HR and procurement.
· OrgDev newsletter
Notes from a Corporate Rebels session with Bayer's Michael Lurie and Lars Bruening.
· —
Reference biography of Bayer's CEO, sourced to Handelsblatt's German-language report on his 2023 appointment.
· HBS case authors
Harvard Business School's own teaching case on DSO, framing Bayer alongside Amazon, Citibank and Dell as companies exploring similar shifts.
· Michael Lurie (Bayer Chief Transformation Officer)
First-person account from Bayer's Chief Transformation Officer on early DSO results: faster decisions, improved revenue and more engaged teams.
· PwC / Niels Hessmann (Bayer Benelux)
Interview with Bayer Benelux's pharmaceuticals head on how DSO is enabling mission-driven outcome focus at the country level.
· Namir Sagheenanajar
A sharply critical outside read on DSO under the headline 'failed experiment' — an explicit counterweight to Bayer's and its consultants' own framing.
· Bill Anderson
Bayer CEO's own words to shareholders on delayering the organisation and consolidating leadership roles under DSO.